Industry Insights Logo

Should We Prepare for a 340B Rebate Model?

SPONSORED CONTENT

As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to operate their 340B programs.  This may include conducting an annual independent audit, financially reconciling the previous fiscal year, getting

Read More »

Supreme Court Backs HHS in Dispute Over DSH Calculation, 340B Providers Condemn Decision Which Could Impact Eligibility for Some Hospitals

The Supreme Court sided with federal health officials this week in a dispute over the Disproportionate Share Hospital (DSH) formula.
The U.S. Supreme Court on Tuesday sided against more than 200 hospitals in a dispute over Medicare disproportionate share hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo Exempts Four More States From 340B Contract Pharmacy Restrictions, GSK Exempts Nebraska, Utah

Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State 340B Contract Pharmacy Lawsuit Roundup: New Filings in Utah

Key briefs were filed recently in state contract pharmacy litigation in Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pillr Health

Q: Tell us some interesting details about your company’s history.

Pillr Health was born from a passion for progress. Building on two decades of experience, we evolved this year with

Read More »

Expert Tip from Cervey

img
img

TIP: Prioritize referral consistency over volume.


When it comes to 340B referral capture, it’s tempting to focus

Read More »

News Alert

Federal Judge Grills Both Sides in Key Hearing on 340B Rebate Dispute

A hearing on five drug industry 340B rebate lawsuits took place April 29 in the U.S. District Court for the District of Columbia.
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Stretching Scarce Federal Resources: How Conway Medical Center Is Redefining 340B’s Impact

SPONSORED CONTENT

The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in the pharmaceutical industry. In addition, there are questions regarding 340B’s scope including the contract pharmacy program and the definition of patient.

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live